Low-dose glucocorticoids in systemic lupus erythematosus: New evidence around use and thresholds
Glucocorticoids are a mainstay of treatment for systemic lupus erythematosus (SLE). But due to long-term adverse effects, dose reduction is becoming a crucial part of treat-to-target management goals. However, data regarding ...
Jun 13, 2024
0
1